APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thrombin (Human)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Thrombin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchThrombin (Human) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Thrombin (Human) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Thrombin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thrombin (Human) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Thrombin (Human) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Thrombin (Human) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Thrombin (Human) include Shanghai RAAS, Hualan Biological, Bayer, Baxter, Vitrolife AB, Sigma-Aldrich Corporation, PromoCell GmbH, Octapharma and Life Technologies Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Thrombin (Human) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Thrombin (Human) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Thrombin (Human) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Thrombin (Human) market size, projected growth trends, production technologies, key applications, and end-use industries.

Thrombin (Human) Segment by Company

Shanghai RAAS

Hualan Biological

Bayer

Baxter

Vitrolife AB

Sigma-Aldrich Corporation

PromoCell GmbH

Octapharma

Life Technologies Corporation

Kedrion

Grifols

CSL

BD Biosciences

AMRESCO Inc

Thrombin (Human) Segment by Type

500IU/Vial

1000IU/Vial

2500IU/Vial

Thrombin (Human) Segment by Application

Biotechnology

Microbiology

Medicine

Others

Thrombin (Human) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thrombin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thrombin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thrombin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Thrombin (Human) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Thrombin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Thrombin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Thrombin (Human) Industry Trends Table 2. Thrombin (Human) Industry Drivers Table 3. Thrombin (Human) Industry Opportunities and Challenges Table 4. Thrombin (Human) Industry Restraints Table 5. Global Thrombin (Human) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Thrombin (Human) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Thrombin (Human) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Thrombin (Human) Sales Market Share by Manufacturers Table 9. Global Thrombin (Human) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Thrombin (Human) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Thrombin (Human) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Thrombin (Human) Manufacturers, Product Type & Application Table 13. Global Thrombin (Human) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Thrombin (Human) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500IU/Vial Table 17. Major Manufacturers of 1000IU/Vial Table 18. Major Manufacturers of 2500IU/Vial Table 19. Global Thrombin (Human) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Thrombin (Human) Sales by Type (2021-2026) & (K Units) Table 21. Global Thrombin (Human) Sales by Type (2027-2032) & (K Units) Table 22. Global Thrombin (Human) Sales Market Share by Type (2021-2026) Table 23. Global Thrombin (Human) Sales Market Share by Type (2027-2032) Table 24. Global Thrombin (Human) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Thrombin (Human) Revenue by Type (2021-2026) & (K Units) Table 26. Global Thrombin (Human) Revenue by Type (2027-2032) & (K Units) Table 27. Global Thrombin (Human) Revenue Market Share by Type (2021-2026) Table 28. Global Thrombin (Human) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Biotechnology Table 30. Major Manufacturers of Microbiology Table 31. Major Manufacturers of Medicine Table 32. Major Manufacturers of Others Table 33. Global Thrombin (Human) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Thrombin (Human) Sales by Application (2021-2026) & (K Units) Table 35. Global Thrombin (Human) Sales by Application (2027-2032) & (K Units) Table 36. Global Thrombin (Human) Sales Market Share by Application (2021-2026) Table 37. Global Thrombin (Human) Sales Market Share by Application (2027-2032) Table 38. Global Thrombin (Human) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Thrombin (Human) Revenue by Application (2021-2026) & (K Units) Table 40. Global Thrombin (Human) Revenue by Application (2027-2032) & (K Units) Table 41. Global Thrombin (Human) Revenue Market Share by Application (2021-2026) Table 42. Global Thrombin (Human) Revenue Market Share by Application (2027-2032) Table 43. Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Thrombin (Human) Sales by Region (2021-2026) & (K Units) Table 45. Global Thrombin (Human) Sales Market Share by Region (2021-2026) Table 46. Global Thrombin (Human) Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Thrombin (Human) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 50. North America Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 51. Europe Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 53. Europe Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 60. Global Thrombin (Human) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Thrombin (Human) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Thrombin (Human) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Thrombin (Human) Revenue Market Share by Region (2021-2026) Table 64. Global Thrombin (Human) Revenue Market Share by Region (2027-2032) Table 65. Shanghai RAAS Company Information Table 66. Shanghai RAAS Business Overview Table 67. Shanghai RAAS Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shanghai RAAS Thrombin (Human) Product Portfolio Table 69. Shanghai RAAS Recent Development Table 70. Hualan Biological Company Information Table 71. Hualan Biological Business Overview Table 72. Hualan Biological Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Hualan Biological Thrombin (Human) Product Portfolio Table 74. Hualan Biological Recent Development Table 75. Bayer Company Information Table 76. Bayer Business Overview Table 77. Bayer Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bayer Thrombin (Human) Product Portfolio Table 79. Bayer Recent Development Table 80. Baxter Company Information Table 81. Baxter Business Overview Table 82. Baxter Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Baxter Thrombin (Human) Product Portfolio Table 84. Baxter Recent Development Table 85. Vitrolife AB Company Information Table 86. Vitrolife AB Business Overview Table 87. Vitrolife AB Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Vitrolife AB Thrombin (Human) Product Portfolio Table 89. Vitrolife AB Recent Development Table 90. Sigma-Aldrich Corporation Company Information Table 91. Sigma-Aldrich Corporation Business Overview Table 92. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio Table 94. Sigma-Aldrich Corporation Recent Development Table 95. PromoCell GmbH Company Information Table 96. PromoCell GmbH Business Overview Table 97. PromoCell GmbH Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. PromoCell GmbH Thrombin (Human) Product Portfolio Table 99. PromoCell GmbH Recent Development Table 100. Octapharma Company Information Table 101. Octapharma Business Overview Table 102. Octapharma Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Octapharma Thrombin (Human) Product Portfolio Table 104. Octapharma Recent Development Table 105. Life Technologies Corporation Company Information Table 106. Life Technologies Corporation Business Overview Table 107. Life Technologies Corporation Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Life Technologies Corporation Thrombin (Human) Product Portfolio Table 109. Life Technologies Corporation Recent Development Table 110. Kedrion Company Information Table 111. Kedrion Business Overview Table 112. Kedrion Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Kedrion Thrombin (Human) Product Portfolio Table 114. Kedrion Recent Development Table 115. Grifols Company Information Table 116. Grifols Business Overview Table 117. Grifols Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Grifols Thrombin (Human) Product Portfolio Table 119. Grifols Recent Development Table 120. CSL Company Information Table 121. CSL Business Overview Table 122. CSL Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. CSL Thrombin (Human) Product Portfolio Table 124. CSL Recent Development Table 125. BD Biosciences Company Information Table 126. BD Biosciences Business Overview Table 127. BD Biosciences Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. BD Biosciences Thrombin (Human) Product Portfolio Table 129. BD Biosciences Recent Development Table 130. AMRESCO Inc Company Information Table 131. AMRESCO Inc Business Overview Table 132. AMRESCO Inc Thrombin (Human) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. AMRESCO Inc Thrombin (Human) Product Portfolio Table 134. AMRESCO Inc Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Thrombin (Human) Distributors List Table 138. Thrombin (Human) Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Thrombin (Human) Product Image Figure 2. Global Thrombin (Human) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thrombin (Human) Market Size (2021-2032) & (US$ Million) Figure 4. Global Thrombin (Human) Sales (2021-2032) & (K Units) Figure 5. Global Thrombin (Human) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Thrombin (Human) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500IU/Vial Image Figure 9. 1000IU/Vial Image Figure 10. 2500IU/Vial Image Figure 11. Global Thrombin (Human) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Thrombin (Human) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Thrombin (Human) Sales Market Share by Type (2021-2032) Figure 14. Global Thrombin (Human) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Thrombin (Human) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Thrombin (Human) Revenue Market Share by Type (2021-2032) Figure 17. Biotechnology Image Figure 18. Microbiology Image Figure 19. Medicine Image Figure 20. Others Image Figure 21. Global Thrombin (Human) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Thrombin (Human) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Thrombin (Human) Sales Market Share by Application (2021-2032) Figure 24. Global Thrombin (Human) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Thrombin (Human) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Thrombin (Human) Revenue Market Share by Application (2021-2032) Figure 27. North America Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Thrombin (Human) Sales Market Share by Country (2021-2032) Figure 29. U.S. Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Thrombin (Human) Sales Market Share by Country (2021-2032) Figure 34. Germany Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Thrombin (Human) Sales Market Share by Country (2021-2032) Figure 41. China Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Thrombin (Human) Sales Market Share by Country (2021-2032) Figure 49. Brazil Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Thrombin (Human) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Thrombin (Human) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Thrombin (Human) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Thrombin (Human) Revenue (2021-2032) & (US$ Million) Figure 60. North America Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Thrombin (Human) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Thrombin (Human) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Thrombin (Human) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Thrombin (Human) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Thrombin (Human) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 500IU/Vial
  • 1000IU/Vial
  • 2500IU/Vial
Applications
  • Biotechnology
  • Microbiology
  • Medicine
  • Others
Companies covered
  • Shanghai RAAS
  • Hualan Biological
  • Bayer
  • Baxter
  • Vitrolife AB
  • Sigma-Aldrich Corporation
  • PromoCell GmbH
  • Octapharma
  • Life Technologies Corporation
  • Kedrion
  • Grifols
  • CSL
  • BD Biosciences
  • AMRESCO Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Thrombin (Human) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Thrombin (Human) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Thrombin (Human) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Thrombin (Human) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Thrombin (Human) Market Dynamics
  1. 2.1 Thrombin (Human) Industry Trends
  2. 2.2 Thrombin (Human) Industry Drivers
  3. 2.3 Thrombin (Human) Industry Opportunities and Challenges
  4. 2.4 Thrombin (Human) Industry Restraints
3 Thrombin (Human) Market by Manufacturers
  1. 3.1 Global Thrombin (Human) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Thrombin (Human) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Thrombin (Human) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Thrombin (Human) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Thrombin (Human) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Thrombin (Human) Manufacturers, Product Type & Application
  7. 3.7 Global Thrombin (Human) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Thrombin (Human) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Thrombin (Human) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Thrombin (Human) Tier 1, Tier 2, and Tier 3
4 Thrombin (Human) Market by Type
  1. 4.1 Thrombin (Human) Type Introduction
  2. 4.1.1 500IU/Vial
  3. 4.1.2 1000IU/Vial
  4. 4.1.3 2500IU/Vial
  5. 4.2 Global Thrombin (Human) Sales by Type
  6. 4.2.1 Global Thrombin (Human) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Thrombin (Human) Sales by Type (2021-2032)
  8. 4.2.3 Global Thrombin (Human) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Thrombin (Human) Revenue by Type
  10. 4.3.1 Global Thrombin (Human) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Thrombin (Human) Revenue by Type (2021-2032)
  12. 4.3.3 Global Thrombin (Human) Revenue Market Share by Type (2021-2032)
5 Thrombin (Human) Market by Application
  1. 5.1 Thrombin (Human) Application Introduction
  2. 5.1.1 Biotechnology
  3. 5.1.2 Microbiology
  4. 5.1.3 Medicine
  5. 5.1.4 Others
  6. 5.2 Global Thrombin (Human) Sales by Application
  7. 5.2.1 Global Thrombin (Human) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Thrombin (Human) Sales by Application (2021-2032)
  9. 5.2.3 Global Thrombin (Human) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Thrombin (Human) Revenue by Application
  11. 5.3.1 Global Thrombin (Human) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Thrombin (Human) Revenue by Application (2021-2032)
  13. 5.3.3 Global Thrombin (Human) Revenue Market Share by Application (2021-2032)
6 Global Thrombin (Human) Sales by Region
  1. 6.1 Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Thrombin (Human) Sales by Region (2021-2032)
  3. 6.2.1 Global Thrombin (Human) Sales by Region (2021-2026)
  4. 6.2.2 Global Thrombin (Human) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Thrombin (Human) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Thrombin (Human) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Thrombin (Human) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Thrombin (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Thrombin (Human) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Thrombin (Human) Revenue by Region
  1. 7.1 Global Thrombin (Human) Revenue by Region
  2. 7.1.1 Global Thrombin (Human) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Thrombin (Human) Revenue by Region (2021-2026)
  4. 7.1.3 Global Thrombin (Human) Revenue by Region (2027-2032)
  5. 7.1.4 Global Thrombin (Human) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Thrombin (Human) Revenue (2021-2032)
  8. 7.2.2 North America Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Thrombin (Human) Revenue (2021-2032)
  11. 7.3.2 Europe Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Thrombin (Human) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Thrombin (Human) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Thrombin (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai RAAS
  2. 8.1.1 Shanghai RAAS Company Information
  3. 8.1.2 Shanghai RAAS Business Overview
  4. 8.1.3 Shanghai RAAS Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai RAAS Thrombin (Human) Product Portfolio
  6. 8.1.5 Shanghai RAAS Recent Developments
  7. 8.2 Hualan Biological
  8. 8.2.1 Hualan Biological Company Information
  9. 8.2.2 Hualan Biological Business Overview
  10. 8.2.3 Hualan Biological Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hualan Biological Thrombin (Human) Product Portfolio
  12. 8.2.5 Hualan Biological Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Thrombin (Human) Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Thrombin (Human) Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Vitrolife AB
  26. 8.5.1 Vitrolife AB Company Information
  27. 8.5.2 Vitrolife AB Business Overview
  28. 8.5.3 Vitrolife AB Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vitrolife AB Thrombin (Human) Product Portfolio
  30. 8.5.5 Vitrolife AB Recent Developments
  31. 8.6 Sigma-Aldrich Corporation
  32. 8.6.1 Sigma-Aldrich Corporation Company Information
  33. 8.6.2 Sigma-Aldrich Corporation Business Overview
  34. 8.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
  36. 8.6.5 Sigma-Aldrich Corporation Recent Developments
  37. 8.7 PromoCell GmbH
  38. 8.7.1 PromoCell GmbH Company Information
  39. 8.7.2 PromoCell GmbH Business Overview
  40. 8.7.3 PromoCell GmbH Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PromoCell GmbH Thrombin (Human) Product Portfolio
  42. 8.7.5 PromoCell GmbH Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Thrombin (Human) Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Life Technologies Corporation
  50. 8.9.1 Life Technologies Corporation Company Information
  51. 8.9.2 Life Technologies Corporation Business Overview
  52. 8.9.3 Life Technologies Corporation Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
  54. 8.9.5 Life Technologies Corporation Recent Developments
  55. 8.10 Kedrion
  56. 8.10.1 Kedrion Company Information
  57. 8.10.2 Kedrion Business Overview
  58. 8.10.3 Kedrion Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kedrion Thrombin (Human) Product Portfolio
  60. 8.10.5 Kedrion Recent Developments
  61. 8.11 Grifols
  62. 8.11.1 Grifols Company Information
  63. 8.11.2 Grifols Business Overview
  64. 8.11.3 Grifols Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Grifols Thrombin (Human) Product Portfolio
  66. 8.11.5 Grifols Recent Developments
  67. 8.12 CSL
  68. 8.12.1 CSL Company Information
  69. 8.12.2 CSL Business Overview
  70. 8.12.3 CSL Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSL Thrombin (Human) Product Portfolio
  72. 8.12.5 CSL Recent Developments
  73. 8.13 BD Biosciences
  74. 8.13.1 BD Biosciences Company Information
  75. 8.13.2 BD Biosciences Business Overview
  76. 8.13.3 BD Biosciences Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BD Biosciences Thrombin (Human) Product Portfolio
  78. 8.13.5 BD Biosciences Recent Developments
  79. 8.14 AMRESCO Inc
  80. 8.14.1 AMRESCO Inc Company Information
  81. 8.14.2 AMRESCO Inc Business Overview
  82. 8.14.3 AMRESCO Inc Thrombin (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AMRESCO Inc Thrombin (Human) Product Portfolio
  84. 8.14.5 AMRESCO Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Thrombin (Human) Value Chain Analysis
  2. 9.1.1 Thrombin (Human) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Thrombin (Human) Production Mode & Process
  6. 9.2 Thrombin (Human) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Thrombin (Human) Distributors
  9. 9.2.3 Thrombin (Human) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst